Acumen Pharmaceuticals Inc (ABOS) — Strategic Asset Allocation Index
Acumen Pharmaceuticals Inc (ABOS) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $70.43 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Acumen Pharmaceuticals Inc (ABOS) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Acumen Pharmaceuticals Inc Strategic Asset Allocation Index (2021–2025)
This chart shows how Acumen Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $70.43 Million USD. For live market cap and overall valuation, see ABOS market cap overview.
Annual Strategic Asset Allocation Index for Acumen Pharmaceuticals Inc (2021–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Acumen Pharmaceuticals Inc from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Acumen Pharmaceuticals Inc (ABOS) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | $0.00 | $- | $0.00 | $70.43 Million | ▼ -33.0 pp |
| 2024 | 33.0% | $59.97 Million | $- | $59.97 Million | $181.82 Million | ▲ +9.6 pp |
| 2023 | 23.4% | $62.55 Million | $- | $62.55 Million | $266.97 Million | ▲ +15.0 pp |
| 2022 | 8.5% | $16.00 Million | $165.00K | $15.84 Million | $188.78 Million | ▼ -5.6 pp |
| 2021 | 14.1% | $31.66 Million | $36.00K | $31.62 Million | $225.18 Million | — |